Abstract
The synergistic nature of non-pharmaceutical interventions (NPIs) for control of COVID makes it difficult to assess the efficacy of any individual strategy. This study uses influenza mortality reduction (IMR) during the pandemic as an indicator of the aggregate efficacy of NPIs to assess their impact on COVID mortality.
Age-adjusted COVID mortality for US states were modeled as a function of four variables: mortality prior to the introduction of NPIs, vaccination rates, IMR relative to historical averages, and population density.
A simple linear model with only these variables explained 69% of the state-to-state variability in age adjusted COVID mortality. The resulting model suggests that NPIs alone prevented 840,000 COVID related deaths in the United States over the course of the pandemic. These results demonstration the utility of IMRs as an indicator of the aggregate impact of NPIs for controlling transmission of respiratory infections, including COVID.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All data were openly available before the initiation of the study from the CDC and the census bureau as listed below. 1. CDC (2023). Weekly U.S. Influenza Surveillance Report. Cent. Dis. Control Prev. https://www.cdc.gov/flu/weekly/index.htm. 2. CDC (2020). COVID Data Tracker. Cent. Dis. Control Prev. https://covid.cdc.gov/covid-data-tracker. 3.Provisional COVID-19 Deaths by Sex and Age | Data | Centers for Disease Control and Prevention https://data.cdc.gov/NCHS/Provisional-COVID-19-Deaths-by-Sex-and-Age/9bhg-hcku/about_data. 4.US Census Bureau (1910). Population Density of the 50 States, the District of Columbia, and Puerto Rico: 1910 to 2020. N. Y. https://www2.census.gov/programs-surveys/decennial/2020/data/apportionment/population-density-data-table.pdf.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
More recent data used for both COVID mortality and vaccination. Added confidence intervals for counterfactual predictions based on Monte Carlo simulations. Prediction of counterfactuals related to full use of NPI's and full vaccination deleted due to model behavior at extreme values.
Data Availability
All data produced in the present study are available upon reasonable request to the author.
https://www.cdc.gov/flu/weekly/index.htm
https://covid.cdc.gov/covid-data-tracker
https://data.cdc.gov/NCHS/Provisional-COVID-19-Deaths-by-Sex-and-Age/9bhg-hcku/about_data
